For many sites the recent increase in utilization of decentralized clinical trials (DCTs) was a forced relationship, being implemented in response to the pandemic, and rushed to rescue trials that would have otherwise failed. Now, the world is in a new decentralized trial era, one in which decentralized solutions are more well-known and accepted, being built into trials proactively. As a result, more sites are being asked to not only learn how to implement these solutions but also know how to successfully utilize decentralized trial elements. Appropriate implementation and successful delivery is no small task!

After 16 years of delivering decentralized elements in trials, MRN has become well-versed with the burdens and issues that sites face when implementing DCTs and the challenges they must overcome all while keeping the patient’s care their top priority. In response, they built an ecosystem of processes and teams to help sites become more successful DCT users.

In this webinar, the featured speakers will share their experience working with sites and delivering decentralized clinical trials to ensure critical data is collected, trials realize the full value of DCTs and sites can run these trials more successfully.

Register for this webinar to learn about ensuring site success through this new era of increased decentralized trial adoption.

Keywords:

Speakers

Stuart Redding, , Medical Research Network

Stuart Redding, CEO, Medical Research Network

Stuart has over 25 years in the clinical research sector, having worked for several sponsors and CROs before joining MRN; Stuart’s experience spans many disciplines including data management, clinical operations, project management, business development, proposals/budgets and marketing. Stuart was one of the MRN founders in 2006 joining the organisation as Head of Project Management; in 2009 Stuart took on the role of Vice President of Global Business Development and Marketing before stepping up as Chief Operating Officer in 2017 and again as Chief Executive Officer in 2022.

Stuart brings incredible insight to the running of decentralized clinical trials, having experienced the many challenges of running clinical trials in traditional models. Stuart has a deep understanding of the organization and the market and will focus on the continued organic growth of the core MRN business.

Message Presenter

Kerry Leyden, Director Site Relationship Management, Medical Research Network

Prior to joining MRN, Kerry worked in pharma and CRO for 15 years, primarily focused on patient engagement, recruitment and retention. She has developed targeted study-specific patient recruitment and retention strategies for large portfolios, and overseen execution in collaboration with study teams, by engaging with sites, identifying, qualifying, and managing specialized vendors and fostering relationships with both localized and global advocacy organizations. Kerry is passionate about patient-centricity and site relationships, striving to ensure the experience for site and patient are equally positive.

Message Presenter

Who Should Attend?

C-suite
VP level
Medical Director
Clinical Development Director
Operational Director
Clinical Director
Clinical Innovation
Patient Engagement
Patient Advocacy
Patient Recruitment
Patient Services
Principal Investigator
Clinical Trial Manager
Study Coordinators
Clinical Research Coordinator
Director Clinical Research

What You Will Learn

Attendees will learn:

What is critical for successful implementation of Home Trial Support and other DCT elements
How the right support for sites can deliver results for all stakeholders
The shared goals that will maximize the value of decentralized clinical trials

Xtalks Partner

MRN

MRN has led the way efficiently delivering high quality complex Decentralized Clinical Trials (DCT) from patients’ homes for over 16 years. We understand the complexities of today’s clinical trial environment and the burden placed on both patients and sites. Our decentralized trial and site support solutions are designed to ease these burdens, therefore accelerating patient recruitment, enrollment, and retention, maximizing the impact of the trial for the pharmaceutical sponsor – getting drugs to market faster. MRN are the catalysts of decentralized trials; combining the right clinical and digital DCT elements, to engineer the right solution for each trial. Learn more about MRN: https://themrn.io/